Symptom Management in African-American Men With Localized Prostate Cancer

NCT ID: NCT00767845

Last Updated: 2016-11-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2006-06-30

Study Completion Date

2008-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: Gathering information about symptom management from patients with localized prostate cancer may help doctors improve patients' quality of life.

PURPOSE: This clinical trial is studying symptom management in African-American men with localized prostate cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

* Develop a symptom management intervention for African-American men treated for localized prostate cancer, with a particular emphasis on low health literacy men.

OUTLINE: Participants are interviewed by the principal investigator over the phone or meet the principal investigator at the Veterans Administration prostate cancer clinic. If the interview is conducted in the clinic, it is held in a private room in the clinic.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer Psychosocial Effects of Cancer and Its Treatment

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

psychosocial effects of cancer and its treatment stage I prostate cancer stage II prostate cancer stage III prostate cancer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionnaire/survey administration

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

DISEASE CHARACTERISTICS:

* Biopsy-proven localized prostate cancer

* Has received treatment for prostate cancer
* Patient self-identifies as being of African-American descent

PATIENT CHARACTERISTICS:

* Able to speak and read in English
* Has an address in order to receive study materials by mail (a street address or post office box)
* Has either a telephone in order to be interviewed OR is able to meet the principal investigator at the Veterans Administration prostate clinic and be interviewed there

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics
Minimum Eligible Age

18 Years

Maximum Eligible Age

120 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Baylor College of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

David Latini

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David M. Latini, PhD

Role: PRINCIPAL_INVESTIGATOR

Baylor College of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dan L. Duncan Cancer Center at Baylor College of Medicine

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BCM-H-19323

Identifier Type: -

Identifier Source: secondary_id

CDR0000600455

Identifier Type: -

Identifier Source: org_study_id